Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control Study

Insulin antibody (IA) may potentially affect a patient’s glycemic control due to its variability in both binding and/or releasing insulin. However, the association between IA titer and daily glycemic variability (GV) is still unknown. We thus performed this cross-sectional, retrospective case-contro...

Full description

Bibliographic Details
Main Authors: Jian Zhu, Lu Yuan, Wen-ji Ni, Yong Luo, Jian-hua Ma
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2019/7304140
id doaj-a0da00c4596f4e3cb6037c34ea55ecdc
record_format Article
spelling doaj-a0da00c4596f4e3cb6037c34ea55ecdc2020-11-24T21:46:30ZengHindawi LimitedJournal of Diabetes Research2314-67452314-67532019-01-01201910.1155/2019/73041407304140Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control StudyJian Zhu0Lu Yuan1Wen-ji Ni2Yong Luo3Jian-hua Ma4Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210012, ChinaDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210012, ChinaDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210012, ChinaDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210012, ChinaDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210012, ChinaInsulin antibody (IA) may potentially affect a patient’s glycemic control due to its variability in both binding and/or releasing insulin. However, the association between IA titer and daily glycemic variability (GV) is still unknown. We thus performed this cross-sectional, retrospective case-control study to assess the relationship between IA titer and mean amplitude glycemic excursion (MAGE) in type 2 diabetes mellitus (T2DM) patients using a continuous glucose monitoring (CGM) system. We recruited 100 eligible patients (IA>5%, IA positive) and divided them into two groups—a low (L) group and a high (H) group—based on their IA titer. The control (C) group consisted of 47 patients (IA≤5%, IA negative) matched for age, BMI, gender, and glycosylated hemoglobin A1c (HbA1c). The CGM determined the GV of enrolled patients. The primary outcome was the relationship between the IA titer and the MAGE, and the secondary outcome was the differences of GV among the three groups. We found that patients in the H group had higher levels of blood glucose fluctuation parameters than those in the L and C groups. The Ln(IA) was positively correlated with Ln(MAGE) even after adjusting for age, gender, BMI, HbA1c, and fasting and postprandial C-peptide(r=0.423, p<0.001). Multiple linear stepwise regression analysis revealed that Ln(IA) was an independent factor of Ln(MAGE) (beta=0.405, p<0.001). In conclusion, the higher circulating IA titer was associated with increased MAGE in T2DM patients, indicating that those patients with elevated IA titer should receive GV assessment and individualized treatment.http://dx.doi.org/10.1155/2019/7304140
collection DOAJ
language English
format Article
sources DOAJ
author Jian Zhu
Lu Yuan
Wen-ji Ni
Yong Luo
Jian-hua Ma
spellingShingle Jian Zhu
Lu Yuan
Wen-ji Ni
Yong Luo
Jian-hua Ma
Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control Study
Journal of Diabetes Research
author_facet Jian Zhu
Lu Yuan
Wen-ji Ni
Yong Luo
Jian-hua Ma
author_sort Jian Zhu
title Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control Study
title_short Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control Study
title_full Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control Study
title_fullStr Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control Study
title_full_unstemmed Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control Study
title_sort association of higher circulating insulin antibody with increased mean amplitude glycemic excursion in patients with type 2 diabetes mellitus: a cross-sectional, retrospective case-control study
publisher Hindawi Limited
series Journal of Diabetes Research
issn 2314-6745
2314-6753
publishDate 2019-01-01
description Insulin antibody (IA) may potentially affect a patient’s glycemic control due to its variability in both binding and/or releasing insulin. However, the association between IA titer and daily glycemic variability (GV) is still unknown. We thus performed this cross-sectional, retrospective case-control study to assess the relationship between IA titer and mean amplitude glycemic excursion (MAGE) in type 2 diabetes mellitus (T2DM) patients using a continuous glucose monitoring (CGM) system. We recruited 100 eligible patients (IA>5%, IA positive) and divided them into two groups—a low (L) group and a high (H) group—based on their IA titer. The control (C) group consisted of 47 patients (IA≤5%, IA negative) matched for age, BMI, gender, and glycosylated hemoglobin A1c (HbA1c). The CGM determined the GV of enrolled patients. The primary outcome was the relationship between the IA titer and the MAGE, and the secondary outcome was the differences of GV among the three groups. We found that patients in the H group had higher levels of blood glucose fluctuation parameters than those in the L and C groups. The Ln(IA) was positively correlated with Ln(MAGE) even after adjusting for age, gender, BMI, HbA1c, and fasting and postprandial C-peptide(r=0.423, p<0.001). Multiple linear stepwise regression analysis revealed that Ln(IA) was an independent factor of Ln(MAGE) (beta=0.405, p<0.001). In conclusion, the higher circulating IA titer was associated with increased MAGE in T2DM patients, indicating that those patients with elevated IA titer should receive GV assessment and individualized treatment.
url http://dx.doi.org/10.1155/2019/7304140
work_keys_str_mv AT jianzhu associationofhighercirculatinginsulinantibodywithincreasedmeanamplitudeglycemicexcursioninpatientswithtype2diabetesmellitusacrosssectionalretrospectivecasecontrolstudy
AT luyuan associationofhighercirculatinginsulinantibodywithincreasedmeanamplitudeglycemicexcursioninpatientswithtype2diabetesmellitusacrosssectionalretrospectivecasecontrolstudy
AT wenjini associationofhighercirculatinginsulinantibodywithincreasedmeanamplitudeglycemicexcursioninpatientswithtype2diabetesmellitusacrosssectionalretrospectivecasecontrolstudy
AT yongluo associationofhighercirculatinginsulinantibodywithincreasedmeanamplitudeglycemicexcursioninpatientswithtype2diabetesmellitusacrosssectionalretrospectivecasecontrolstudy
AT jianhuama associationofhighercirculatinginsulinantibodywithincreasedmeanamplitudeglycemicexcursioninpatientswithtype2diabetesmellitusacrosssectionalretrospectivecasecontrolstudy
_version_ 1725901725605298176